Literature DB >> 25233929

ETV5 transcription program links BDNF and promotion of EMT at invasive front of endometrial carcinomas.

Lorena Alonso-Alconada1, Nuria Eritja2, Laura Muinelo-Romay3, Jorge Barbazan1, Rafael Lopez-Lopez1, Xavier Matias-Guiu2, Antonio Gil-Moreno4, Xavier Dolcet2, Miguel Abal5.   

Abstract

Myometrial infiltration represents a main clinical determinant of endometrial carcinomas (EC) presenting as aggressive high-grade deeply invasive neoplasms, substantially associated with risk of recurrence and death. The up-regulation of ETV5 transcription factor linked to the promotion of epithelial to mesenchymal transition is considered as a basic mechanism underlying the initial steps of EC invasion. In this work, we aimed to investigate the transcription program of tumor invasion regulated by ETV5. We performed a comparative Chip-on-chip analysis at invasive front and superficial area of human EC. ETV5 specific binding to promoter regions of genes related to cellular migration, adhesion and invasion at deep invasion tumor areas highlighted the relevance of neural networks associated with cellular plasticity. Interestingly, brain-derived neurotrophic factor (BDNF) demonstrated a principal role orchestrating ETV5-mediated epithelial-to-mesenchymal transition in endometrial cancer. Impairment of the BDNF/tropomyosin-related kinase B (TrkB)/extracellular signal-regulated kinase axis in endometrial cancer cell lines reversed the aggressive and invasive phenotype promoted by the up-regulation of ETV5 at the invasive front of EC. Likewise, BDNF directly impacted on the efficiency of ETV5 promoted metastasis in a mice model of endometrial distant dissemination. These results translate the recognized role of BDNF/TrkB on neural plasticity into a relevant cancer metastasis event; suggest common mechanisms shared by neural development and tumor invasion; and offer new therapeutic opportunities specifically directed against disseminated disease in endometrial cancer.
© The Author 2014. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25233929     DOI: 10.1093/carcin/bgu198

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  7 in total

1.  [High expression of MMP20 may be a potential prognostic factor for poor outcomes of patients with endometrial carcinoma].

Authors:  Qian Zhao; Shu Liu
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2018-09-30

2.  Endometrial Tumour Microenvironment.

Authors:  Carlos Casas-Arozamena; Miguel Abal
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  A human endogenous retrovirus-derived gene that can contribute to oncogenesis by activating the ERK pathway and inducing migration and invasion.

Authors:  Cécile Lemaître; Jhen Tsang; Caroline Bireau; Thierry Heidmann; Marie Dewannieux
Journal:  PLoS Pathog       Date:  2017-06-26       Impact factor: 6.823

4.  ALCAM shedding at the invasive front of the tumor is a marker of myometrial infiltration and promotes invasion in endometrioid endometrial cancer.

Authors:  Jaume Reventos; Antonio Gil-Moreno; Eva Colas; Laura Devis; Elena Martinez-Garcia; Cristian P Moiola; Maria Teresa Quiles; Maria Antonia Arbos; Tomita Vasilica Stirbat; Françoise Brochard-Wyart; Ángel García; Lorena Alonso-Alconada; Miguel Abal; Berta Diaz-Feijoo; William Thomas; Sylvie Dufour; Gemma Mancebo; Francesc Alameda
Journal:  Oncotarget       Date:  2018-03-30

Review 5.  Uncoupling Traditional Functionalities of Metastasis: The Parting of Ways with Real-Time Assays.

Authors:  Sagar S Varankar; Sharmila A Bapat
Journal:  J Clin Med       Date:  2019-06-28       Impact factor: 4.241

6.  Biological and prognostic value of ETV5 in high-grade serous ovarian cancer.

Authors:  Lu Zhang; Ruiting Fu; Ping Liu; Lijun Wang; Weihua Liang; Hong Zou; Wei Jia; Lin Tao
Journal:  J Ovarian Res       Date:  2021-11-04       Impact factor: 4.234

7.  Improving Risk Assessment for Metastatic Disease in Endometrioid Endometrial Cancer Patients Using Molecular and Clinical Features: An NRG Oncology/Gynecologic Oncology Group Study.

Authors:  Yovanni Casablanca; Guisong Wang; Heather A Lankes; Chunqiao Tian; Nicholas W Bateman; Caela R Miller; Nicole P Chappell; Laura J Havrilesky; Amy Hooks Wallace; Nilsa C Ramirez; David S Miller; Julie Oliver; Dave Mitchell; Tracy Litzi; Brian E Blanton; William J Lowery; John I Risinger; Chad A Hamilton; Neil T Phippen; Thomas P Conrads; David Mutch; Katherine Moxley; Roger B Lee; Floor Backes; Michael J Birrer; Kathleen M Darcy; George Larry Maxwell
Journal:  Cancers (Basel)       Date:  2022-08-23       Impact factor: 6.575

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.